| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |